Coronary Revascularization in Patients With Cancer
- PMID: 37143711
- PMCID: PMC10119009
- DOI: 10.1007/s11936-023-00982-9
Coronary Revascularization in Patients With Cancer
Abstract
Purpose of review: The treatment of coronary artery disease (CAD) in cancer patients is an evolving landscape. Recent data emphasizes the importance of aggressive management of cardiovascular risk factors and diseases in improving cardiovascular health in this unique group of patients regardless of cancer type or stage.
Recent findings: Novel cancer therapeutics such as immune therapies and proteasome inhibitors have been associated with CAD. Recent stent technologies may safely allow for shorter duration (< 6 months) of dual antiplatelet therapy post-percutaneous coronary interventions. Intracoronary imaging may be useful in the decision making process in terms of stent positioning and healing.
Summary: Large registry studies have partially filled a gap left by the lack of randomized controlled trials in the treatment of CAD in cancer patients. Cardio-oncology is gaining traction as a major sub-specialty in the cardiology field given the release of the first European Society of Cardiology - Cardio-oncology guidelines in 2022.
Keywords: ACS; Acute coronary syndrome; CAD; Cancer; Cardio-oncology; Coronary artery disease; Myocardial infarction; PCI; Radiation.
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of InterestBala Pushparaji declares that he has no conflict of interest. Teodora Donisan declares that she has no conflict of interest. Dinu Valentin Balanescu declares that he has no conflict of interest. Jong Kun Park declares that he has no conflict of interest. Dominique J. Monlezun declares that he has no conflict of interest. Abdelrahman Ali declares that he has no conflict of interest. Ibrahim Halil Inanc declares that he has no conflict of interest. Jaime Caballero declares that he has no conflict of interest. Mehmet Cilingiroglu declares that he has no conflict of interest. Konstantinos Marmagkiolis declares that he has no conflict of interest. Cezar Iliescu declares that he has no conflict of interest.
Figures
References
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Murphy SL, Kochanek KD, Xu JA, Arias E, National Center for Health Statistics (U.S.). Division of vital statistics. Mortality in the United States, 2020. Published Date: 12/22/2021. Series: NCHS data brief no. 427. URL: https://stacks.cdc.gov/view/cdc/112079 - PubMed
-
- Amsterdam EA, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228. doi: 10.1016/j.jacc.2014.09.017. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
